In 2023, the leading autoimmune drug was Humira, generating around 14.4 billion U.S. dollars in global sales, while Stelara as second made nearly 11 billion U.S. dollars. This statistic illustrates some of the top-selling and best-known autoimmune drugs worldwide in 2023.
Leading autoimmune drugs worldwide in 2023
(in billion U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (February 23, 2024). Leading autoimmune drugs worldwide in 2023 (in billion U.S. dollars) [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/1275478/top-selling-autoimmune-drugs-worldwide/
Statista. "Leading autoimmune drugs worldwide in 2023 (in billion U.S. dollars)." Chart. February 23, 2024. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/1275478/top-selling-autoimmune-drugs-worldwide/
Statista. (2024). Leading autoimmune drugs worldwide in 2023 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/1275478/top-selling-autoimmune-drugs-worldwide/
Statista. "Leading Autoimmune Drugs Worldwide in 2023 (in Billion U.S. Dollars)." Statista, Statista Inc., 23 Feb 2024, https://www.statista.com/statistics/1275478/top-selling-autoimmune-drugs-worldwide/
Statista, Leading autoimmune drugs worldwide in 2023 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/1275478/top-selling-autoimmune-drugs-worldwide/ (last visited November 21, 2024)
Leading autoimmune drugs worldwide in 2023 (in billion U.S. dollars) [Graph], Statista, February 23, 2024. [Online]. Available: https://www.statista.com/statistics/1275478/top-selling-autoimmune-drugs-worldwide/
